Potrero Medical Closes $26.6M Series C Financing

Joe Urban, CEO of Potrero Medical (PRNewsfoto/Potrero Medical, Inc.)
Joe Urban, CEO of Potrero Medical (PRNewsfoto/Potrero Medical, Inc.)

Potrero Medical, Inc., a San Francisco, CA-based predictive health company focused on using smart sensors and analytics for early detection of critical illnesses, closed a $26.6m Series C financing.

The round was led by China-focused healthcare investment firm GT Healthcare Capital Partners and Sonder Capital.

The funding will support further commercialization efforts of the company’s flagship product, the Accuryn® Monitoring System, and develop an artificial intelligence platform to assist physicians with early intervention of life­ threatening events, such as Acute Kidney Injury (AKI).

Led by Joe Urban, CEO, Potrero Medical provides the Accuryn® Monitoring System, which uses a smart sensor to accurately monitor Intensive Care Unit (ICU) patients’ vital signs in real-time. The technology can fully integrate physiological measurements for intra-abdominal pressure, urine output, and core body temperature.
The Accuryn System is distributed by Medline, a global manufacturer and distributor serving the healthcare industry with more than 1,200 direct sales representatives.



Join the discussion